Nanovista Inc.’s mission is to save lives by enhancing state-of-the-art medical interventions. Specifically, we focus on providing multimodal visualization agents designed to improve the performance of image-guided high-precision cancer therapy. Nanovista specializes in multimodal visualization agents designed to improve the performance of image-guided interventions such as surgery, radiotherapy and drug delivery. Our lead product is a nanotechnology-based imaging agent that has demonstrated safe and effective tumor and malignant lymph node visualization in 10 different preclinical solid tumor models. It also provides prolonged imaging window suitable for both pre-operative and intra-operative imaging using x-ray computed tomography (CT) and fluorescence optical imaging following a single injection.